Search

everythinglearnresearchcommunity

for

Search:↓

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

DEC cells show promise as a safe and effective treatment for Duchenne muscular dystrophy.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Blocking interferon-gamma might help treat various autoimmune diseases.

CG2001 is safe and well-tolerated for treating hair loss, with fewer side effects than oral finasteride.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

The committee decided not to approve the drug due to low effectiveness and high risks.

CS12192 effectively treats alopecia areata with better safety than current options.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

miR-200c-3p could help diagnose and treat alopecia areata.

CG2001 is safe, well-tolerated, and a promising treatment for hair loss with fewer side effects.

Tocilizumab might be an effective treatment for COVID-19.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Blocking certain immune signals can reduce skin damage from radiation therapy.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Cepharanthine analogues, especially tetrandrine, show potential for treating COVID-19.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

RCS-01 cell therapy is safe and improves skin gene expression.

Biosimilars lower costs but don't significantly improve access.

Vitamin D receptor binds similarly to natural and synthetic ligands, affecting gene regulation.

CG2001 is safe and well-tolerated for treating hair loss in men.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.

Certolizumab effectively treats psoriasis and psoriatic arthritis with fewer side effects than adalimumab.